Abstract
Vascular endothelial growth factor (VEGF) promotes angiogenesis, and elevated levels are found in plaques of psoriasis. Two VEGF polymorphisms, +405 and -460, are associated with early-onset psoriasis and are close to the functional activator protein-1 site (+419) through which retinoids, an established systemic therapy for psoriasis, can block production of VEGF. We report that peripheral blood mononuclear cells (PBMCs) and epidermal keratinocytes (KC) from patients with psoriasis demonstrate differential, genotype-dependent, regulation of VEGF. For PBMCs, VEGF genotype distinguishes two groups of patients with psoriasis - "high and low VEGF producers" (P
| Original language | English |
|---|---|
| Pages (from-to) | 453-459 |
| Number of pages | 6 |
| Journal | Journal of Investigative Dermatology |
| Volume | 126 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Feb 2006 |